In conclusion, our data indicate that uPAR is required for the cell migration and invasion machinery of chondrosarcoma cells and suggest that RERF peptide may be regarded as a prototype to generate new therapeutic agents for the treatment of unresectable or metastasized chondrosarcoma. Here, PLAUR is linked to chondrosarcoma.